Centene Corporation (NYSE:CNC – Get Free Report) has received an average recommendation of “Hold” from the twenty-one brokerages that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have given a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $40.00.
CNC has been the subject of several research reports. Morgan Stanley raised their price objective on shares of Centene from $28.00 to $38.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 14th. Wells Fargo & Company lowered their price target on shares of Centene from $41.00 to $35.00 and set an “equal weight” rating for the company in a report on Wednesday, November 12th. Cantor Fitzgerald upped their price objective on Centene from $38.00 to $41.00 and gave the stock a “neutral” rating in a report on Thursday, October 30th. Sanford C. Bernstein reissued an “outperform” rating and set a $45.00 price objective (up from $36.00) on shares of Centene in a report on Friday, November 21st. Finally, Mizuho raised their target price on shares of Centene from $28.00 to $40.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th.
Check Out Our Latest Analysis on Centene
Hedge Funds Weigh In On Centene
Centene Price Performance
Shares of CNC stock opened at $37.89 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.08 and a quick ratio of 1.10. The stock’s fifty day simple moving average is $36.24 and its 200 day simple moving average is $37.97. Centene has a one year low of $25.08 and a one year high of $66.81. The firm has a market cap of $18.63 billion, a price-to-earnings ratio of -3.50, a P/E/G ratio of 1.24 and a beta of 0.49.
Centene (NYSE:CNC – Get Free Report) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $0.50 earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.71. Centene had a negative net margin of 2.85% and a positive return on equity of 7.82%. The firm had revenue of $49.69 billion for the quarter, compared to analysts’ expectations of $47.50 billion. During the same period in the prior year, the firm earned $1.62 earnings per share. The company’s quarterly revenue was up 18.2% compared to the same quarter last year. On average, analysts expect that Centene will post 6.86 earnings per share for the current fiscal year.
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
See Also
- Five stocks we like better than Centene
- 10 Best Airline Stocks to Buy
- Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
- Overbought Stocks Explained: Should You Trade Them?
- Congress Beat the Market Again—Here Are the 3 Stocks They Bought
- What is a SEC Filing?
- Go on a Shopping Spree With 3 Top Retail ETFs
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
